Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1983 May; 76(5): 386–392.
PMCID: PMC1439174

Pathogenesis and treatment of acute intermittent porphyria: discussion paper.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Albers JW, Robertson WC, Jr, Daube JR. Electrodiagnostic findings in acute porphyric neuropathy. Muscle Nerve. 1978 Jul-Aug;1(4):292–296. [PubMed]
  • Beattie AD, Moore MR, Goldberg A, Ward RL. Acute intermittent porphyria: response of tachycardia and hypertension to propranolol. Br Med J. 1973 Aug 4;3(5874):257–260. [PMC free article] [PubMed]
  • Becker DM, Kramer S. The neurological manifestations of porphyria: a review. Medicine (Baltimore) 1977 Sep;56(5):411–423. [PubMed]
  • Becker DM, Kramer S, Viljoen JD. Delta-aminolevulinic acid uptake by rabbit brain cerebral cortex. J Neurochem. 1974 Nov;23(5):1019–1023. [PubMed]
  • BERLIN L, COTTON R. Gastro-intestinal manifestations of porphyria. Am J Dig Dis. 1950 Apr;17(4):110–114. [PubMed]
  • Biagini R, Tignani R, Fifi AR, Nappini L. Aucte intermittent porphyria and epilepsy. Arch Dis Child. 1979 Aug;54(8):644–645. [PMC free article] [PubMed]
  • Bonkowsky HL, Sinclair PR, Emery S, Sinclair JF. Seizure management in acute hepatic porphyria: risks of valproate and clonazepam. Neurology. 1980 Jun;30(6):588–592. [PubMed]
  • Bonkowsky HL, Tschudy DP, Collins A, Doherty J, Bossenmaier I, Cardinal R, Watson CJ. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad Sci U S A. 1971 Nov;68(11):2725–2729. [PubMed]
  • Bonkowsky HL, Tschudy DP, Weinbach EC, Ebert PS, Doherty JM. Porphyrin synthesis and mitochondrial respiration in acute intermittent porphyria: studies using cultured human fibroblasts. J Lab Clin Med. 1975 Jan;85(1):93–102. [PubMed]
  • Brennan MJ, Cantrill RC. Delta-aminolaevulinic acid is a potent agonist for GABA autoreceptors. Nature. 1979 Aug 9;280(5722):514–515. [PubMed]
  • Cavanagh JB, Ridley AR. The nature of the neuropathy complicating acute intermittent porphyria. Lancet. 1967 Nov 11;2(7524):1023–1024. [PubMed]
  • Cutler MG, Dick JM, Moore MR. Effect of delta-aminolevulinic acid on frog nerve-muscle function. Life Sci. 1978 Nov 27;23(22):2233–2238. [PubMed]
  • Cutler MG, Moore MR, Dick JM. Effects of delta-aminolaevulinic acid on contractile activity of rabbit duodenum. Eur J Pharmacol. 1980 Jun 27;64(4):221–230. [PubMed]
  • Dhar GJ, Bossenmaier I, Petryka ZJ, Cardinal R, Watson CJ. Effects of hematin in hepatic porphyria. Further studies. Ann Intern Med. 1975 Jul;83(1):20–30. [PubMed]
  • Dichter HN, Taddeini L, Lin S, Ayala GF. Delta amino levulinic acid. Effect of a porphyrin precursor on an isolated neuronal preparation. Brain Res. 1977 Apr 22;126(1):189–195. [PubMed]
  • Doss M, Becker U, Peter HJ, Kaffarnik H. Drug safety in porphyria: risks of valproate and metoclopramide. Lancet. 1981 Jul 11;2(8237):91–91. [PubMed]
  • Douer D, Weinberger A, Pinkhas J, Atsmon A. Treatment of acute intermittent porphyria with large doses of propranolol. JAMA. 1978 Aug 25;240(8):766–768. [PubMed]
  • Dowdle E, Mustard P, Spong N, Eales L. The metabolism of (5-14C)delta-aminolaevulic acid in normal and porphyric human subjects. Clin Sci. 1968 Apr;34(2):233–251. [PubMed]
  • Gentz J, Johansson S, Lindblad B, Lindstedt S, Zetterström R. Exertion of delta-aminolevulinic acid in hereditary tyrosinemia. Clin Chim Acta. 1969 Feb;23(2):257–263. [PubMed]
  • GIBSON JB, GOLDBERG A. The neuropathology of acute porphyria. J Pathol Bacteriol. 1956 Apr;71(2):495–509. [PubMed]
  • GOLDBERG A. Acute intermittent porphyria: a study of 50 cases. Q J Med. 1959 Apr;28(110):183–209. [PubMed]
  • Graham DJ, Brodie MJ, McColl KE, Moore MR, Goldberg A. Quantitation of 3-ethyl-5-hydroxy-4,5-dimethyl-delta 3-pyrrolin-2-one in the urine of patients with acute intermittent porphyria. Eur J Clin Invest. 1979 Feb;9(1):49–53. [PubMed]
  • Granick S, Sassa S, Granick JL, Levere RD, Kappas A. Assays for porphyrins, delta-aminolevulinic-acid dehydratase, and porphyrinogen synthetase in microliter samples of whole blood: applications to metabolic defects involving the heme pathway. Proc Natl Acad Sci U S A. 1972 Sep;69(9):2381–2385. [PubMed]
  • HELLMAN ES, TSCHUDY DP, BARTTER FC. Abnormal electrolyte and water metabolism in acute intermittent porphyria. The transient inappropriate secretion of antidiuretic hormone. Am J Med. 1962 May;32:734–746. [PubMed]
  • Houston AB, Brodie MJ, Moore MR, Thompson GG, Stephenson JB. Hereditary coproporphyria and epilepsy. Arch Dis Child. 1977 Aug;52(8):646–650. [PMC free article] [PubMed]
  • Irvine DG. Kryptopyrrole and other monopyrroles in molecular neurobiology. Int Rev Neurobiol. 1974;16(0):145–182. [PubMed]
  • Labbe RF. Metabolic anomalies in porphyria. The result of impaired biological oxidation? Lancet. 1967 Jun 24;1(7504):1361–1364. [PubMed]
  • Larson AW, Wasserstrom WR, Felsher BF, Chih JC. Posttraumatic epilepsy and acute intermittent porphyria: effects of phenytoin, carbamazepine, and clonazepam. Neurology. 1978 Aug;28(8):824–828. [PubMed]
  • Loots JM, Becker DM, Meyer BJ, Goldstuck N, Kramer S. The effect of porphyrin precursors on monosynaptic reflex activity in the isolated hemisected frog spinal cord. J Neural Transm. 1975;36(1):71–81. [PubMed]
  • McColl KE, Moore MR, Thompson GG, Goldberg A. Treatment with haematin in acute hepatic porphyria. Q J Med. 1981 Spring;50(198):161–174. [PubMed]
  • McColl KE, Moore MR, Thompson GG, Goldberg A. Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities. J Med Genet. 1982 Aug;19(4):271–276. [PMC free article] [PubMed]
  • McGillion FB, Thompson GG, Moore MR, Goldberg A. The passage of delta-aminolaevulinic acid across the blood-brain barrier of the rat: effect of ethanol. Biochem Pharmacol. 1974 Jan 15;23(2):472–474. [PubMed]
  • McGillion FB, Thompson GG, Goldberg A. Tissue uptake of o-aminolaevulinic acid. Biochem Pharmacol. 1975 Jan 15;24(2):99–301. [PubMed]
  • Marcus RJ, Wetterberg L, Yuwiler A, Winters WD. Electroencephalographic and behavioral effects of experimental porphyria in the rat. Electroencephalogr Clin Neurophysiol. 1970 Dec;29(6):602–607. [PubMed]
  • MELBY JC, STREET JP, WATSON CJ. Chlorpromazine in the treatment of porphyria. J Am Med Assoc. 1956 Sep 15;162(3):174–178. [PubMed]
  • Meyer UA, Strand LJ, Doss M, Rees AC, Marver HS. Intermittent acute porphyria--demonstration of a genetic defect in porphobilinogen metabolism. N Engl J Med. 1972 Jun 15;286(24):1277–1282. [PubMed]
  • Moore MR. International review of drugs in acute porphyria--1980. Int J Biochem. 1980;12(5-6):1089–1097. [PubMed]
  • Mustajoki P, Seppălăinen AM. Neuropathy in latent hereditary hepatic porphyria. Br Med J. 1975 May 10;2(5966):310–312. [PMC free article] [PubMed]
  • Nicoll RA. The interaction of porphyrin precursors with GABA receptors in the isolated frog spinal cord. Life Sci. 1976 Aug 15;19(4):521–525. [PubMed]
  • Paterniti JR, Jr, Simone JJ, Beattie DS. Detection and regulation of delta-aminolevulinic acid synthetase activity in the rat brain. Arch Biochem Biophys. 1978 Jul;189(1):86–91. [PubMed]
  • Percy VA, Shanley BC. Prophyrin precursors in blood, urine and cerebrospinal fluid in acute porphyria. S Afr Med J. 1977 Jul 30;52(6):219–222. [PubMed]
  • Percy VA, Shanley BC. Studies on haem biosynthesis in rat brain. J Neurochem. 1979 Dec;33(6):1267–1274. [PubMed]
  • Perlroth MG, Tschudy DP, Waxman A, Odell WD. Abnormalities of growth hormone regulation in acute intermittent porphyria. Metabolism. 1967 Jan;16(1):87–90. [PubMed]
  • Piepkorn MW, Hamernyik P, Labbé RF. Modified erythrocyte uroporphyrinogen I synthase assay, and its clinical interpretation. Clin Chem. 1978 Oct;24(10):1751–1754. [PubMed]
  • Ridley A. The neuropathy of acute intermittent porphyria. Q J Med. 1969 Jul;38(151):307–333. [PubMed]
  • Ridley A, Hierons R, Cavanagh JB. Tachycardia and the neuropathy of porphyria. Lancet. 1968 Sep 28;2(7570):708–710. [PubMed]
  • Sassa S, Solish G, Levere RD, Kappas A. Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait. J Exp Med. 1975 Sep 1;142(3):722–731. [PMC free article] [PubMed]
  • Schley G, Bock KD, Hocevar V, Merguet P, Rausch-Stroomann JG, Schröder E, Schümann HJ. Hochdruck und Tachykardie bei der akuten intermittierenden Porphyrie. Klin Wochenschr. 1970 Jan 1;48(1):36–42. [PubMed]
  • Shanley BC, Neethling AC, Percy VA, Carstens M. Neurochemical aspects of porphyria. Studies on the possible neurotoxicity of delta-aminolaevulinic acid. S Afr Med J. 1975 Mar 29;49(14):576–580. [PubMed]
  • Smith AG, De Matteis F. Drugs and the hepatic porphyrias. Clin Haematol. 1980 Jun;9(2):399–425. [PubMed]
  • Sorensen AW, With TK. Persistent pareses after porphyric attacks. S Afr Med J. 1971 Sep 25;:101–103. [PubMed]
  • Stein JA, Tschudy DP. Acute intermittent porphyria. A clinical and biochemical study of 46 patients. Medicine (Baltimore) 1970 Jan;49(1):1–16. [PubMed]
  • Tishler PV, Gordon BJ, O'Connor JA. The adsorption of porphyrins and porphyrin precursors by sorbents: a potential therapy for the porphyrias. Methods Find Exp Clin Pharmacol. 1982;4(2):125–131. [PubMed]
  • Watson CJ, Pierach CA, Bossenmaier I, Cardinal R. Use of hematin in the acute attack of the "inducible" hepatic prophyrias. Adv Intern Med. 1978;23:265–286. [PubMed]
  • Waxman AD, Berk PD, Schalch D, Tschudy DP. Isolated adrenocorticotrophic hormone deficiency in acute intermittent porphyria. Ann Intern Med. 1969 Feb;70(2):317–323. [PubMed]
  • Wider de Xifra EA, Batlle AM, Stella AM, Malamud S. Acute intermittent porphyria--another approach to therapy. Int J Biochem. 1980;12(5-6):819–822. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press